Medscape1d
WHO: Alcohol Cancer Warning Labels Should Be Mandatory
The European Union is home to the world’s heaviest drinkers, who lack awareness of its link with a range of cancers.
Le Lézard5d
Pfizer's TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer
Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...